Literature DB >> 27993995

In neonates S100A8/S100A9 alarmins prevent the expansion of a specific inflammatory monocyte population promoting septic shock.

Anna S Heinemann1, Sabine Pirr1, Beate Fehlhaber1, Lara Mellinger1, Johanna Burgmann1, Mandy Busse1, Marco Ginzel1, Judith Friesenhagen1, Maren von Köckritz-Blickwede2,3, Thomas Ulas4, Constantin S von Kaisenberg5, Johannes Roth6,7, Thomas Vogl6,7, Dorothee Viemann8.   

Abstract

The high susceptibility of newborn infants to sepsis is ascribed to an immaturity of the neonatal immune system, but the molecular mechanisms remain unclear. Newborn monocytes massively release the alarmins S100A8/S100A9. In adults, these are major regulators of immunosuppressive myeloid-derived suppressor cells (MDSCs). We investigated whether S100A8/S100A9 cause an expansion of monocytic MDSCs (Mo-MDSCs) in neonates, thereby contributing to an immunocompromised state. Mo-MDSCs have been assigned to CD14+/human leukocyte antigen (HLA)-DR-/low/CD33+ monocytes in humans and to CD11b+/Gr-1int/Ly6G-/Ly6Chi cells in mice. We found monocytes with these phenotypes significantly expanded in their respective newborns. Functionally, however, they did not prove immunosuppressive but rather responded inflammatorily to microbial stimulation. Their expansion did not correlate with high S100A8/S100A9 levels in cord blood. Murine studies revealed an excessive expansion of CD11b+/Gr-1int/Ly6G-/Ly6Chi monocytes in S100A9-/- neonates compared to wild-type neonates. This strong baseline expansion was associated with hyperinflammatory responses during endotoxemia and fatal septic courses. Treating S100A9-/- neonates directly after birth with S100A8/S100A9 alarmins prevented excessive expansion of this inflammatory monocyte population and death from septic shock. Our data suggest that a specific population of inflammatory monocytes promotes fatal courses of sepsis in neonates if its expansion is not regulated by S100A8/S100A9 alarmins.-Heinemann, A. S., Pirr, S., Fehlhaber, B., Mellinger, L., Burgmann, J., Busse, M., Ginzel, M., Friesenhagen, J., von Köckritz-Blickwede, M., Ulas, T., von Kaisenberg, C. S., Roth, J., Vogl, T., Viemann, D. In neonates S100A8/S100A9 alarmins prevent the expansion of a specific inflammatory monocyte population promoting septic shock. © FASEB.

Entities:  

Keywords:  MDSC; calprotectin; myeloid cells; newborn; sepsis

Mesh:

Substances:

Year:  2016        PMID: 27993995     DOI: 10.1096/fj.201601083R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  18 in total

1.  [Expressions of inflammatory cytokines in mouse peritoneal macrophages induced by MRP8/MRP14 in vitro].

Authors:  Juan Wang; Lei Li; Hai-Hua Luo; Yong Jiang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

Review 2.  Newborn susceptibility to infection vs. disease depends on complex in vivo interactions of host and pathogen.

Authors:  Byron Brook; Danny Harbeson; Rym Ben-Othman; Dorothee Viemann; Tobias R Kollmann
Journal:  Semin Immunopathol       Date:  2017-11-02       Impact factor: 9.623

3.  Group B streptococci infection model shows decreased regulatory capacity of cord blood cells.

Authors:  Kriszta Molnar; Hannah Riedel; Julian Schwarz; Stefanie Dietz; Bärbel Spring; Laura Haag; Christian F Poets; Christian Gille; Natascha Köstlin-Gille
Journal:  Pediatr Res       Date:  2022-02-14       Impact factor: 3.756

Review 4.  Myeloid-derived suppressor cells coming of age.

Authors:  Filippo Veglia; Michela Perego; Dmitry Gabrilovich
Journal:  Nat Immunol       Date:  2018-01-18       Impact factor: 25.606

Review 5.  Epigenetic regulation of pediatric and neonatal immune responses.

Authors:  Jennifer Bermick; Matthew Schaller
Journal:  Pediatr Res       Date:  2021-07-08       Impact factor: 3.756

6.  DNA Methylation Analysis to Unravel Altered Genetic Pathways Underlying Early Onset and Late Onset Neonatal Sepsis. A Pilot Study.

Authors:  Sheila Lorente-Pozo; Paula Navarrete; María José Garzón; Inmaculada Lara-Cantón; Jesús Beltrán-García; Rebeca Osca-Verdegal; Salvador Mena-Mollá; Eva García-López; Máximo Vento; Federico V Pallardó; José Luis García-Giménez
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

7.  Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice.

Authors:  Yufeng Liu; Michela Perego; Qiang Xiao; Yumei He; Shuyu Fu; Juan He; Wangkai Liu; Xing Li; Yanlai Tang; Xiaoyu Li; Weiming Yuan; Wei Zhou; Fan Wu; Chunhong Jia; Qiliang Cui; George S Worthen; Erik A Jensen; Dmitry I Gabrilovich; Jie Zhou
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 19.456

8.  High Amounts of S100-Alarmins Confer Antimicrobial Activity on Human Breast Milk Targeting Pathogens Relevant in Neonatal Sepsis.

Authors:  Sabine Pirr; Manuela Richter; Beate Fehlhaber; Julia Pagel; Christoph Härtel; Johannes Roth; Thomas Vogl; Dorothee Viemann
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

Review 9.  Cord-Blood-Derived Professional Antigen-Presenting Cells: Functions and Applications in Current and Prospective Cell Therapies.

Authors:  Sarah Cunningham; Holger Hackstein
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

10.  Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation.

Authors:  Yu-Mei He; Xing Li; Michela Perego; Yulia Nefedova; Andrew V Kossenkov; Erik A Jensen; Valerian Kagan; Yu-Feng Liu; Shu-Yu Fu; Qing-Jian Ye; Yan-Hong Zhou; Lai Wei; Dmitry I Gabrilovich; Jie Zhou
Journal:  Nat Med       Date:  2018-01-15       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.